PharmaNova Inc. is a privately held, specialty drug development company founded on the re-purposing and/or reformulation of already commercialized drugs using our proprietary NovaSperse℠ nanoparticle technology and other complementary formulation and drug delivery technologies.

• Our nanoparticle technology provides amorphous nanoparticles with precisely controlled size, shape and distribution.

• We develop nanoparticulate formulations with specific APIs for pharmaceutical clients under fee-for-service contracts.

We also are seeking partners to develop and commercialize non-hormonal treatments for the hot flashes of the menopause and for the treatments of prostate and breast cancers.